What's New for the Patient With ER+/HER2- MBC Progressing on CDK 4/6 Inhibitor Therapy? Expert Pe...
ฝัง
- เผยแพร่เมื่อ 19 ธ.ค. 2024
- Join the experts for recent updates on estrogen receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer (MBC) progressing on cyclin-dependent kinase (CDK) 4/6 inhibitors. Learning Objectives & Disclosures: www.medscape.o...
